5397-72-8

Usage

Uses

Due to the limited information available about 1-[2-(Ammoniooxy)ethoxy]benzene chloride, its specific applications are not well-defined. However, based on its chemical structure and classification, it may potentially be used in the following industries:
Used in Chemical Industry:
1-[2-(Ammoniooxy)ethoxy]benzene chloride may be used as a chemical intermediate for the synthesis of various organic compounds and materials, given its unique structure containing ammonium, oxygen, and chloride groups.
Used in Pharmaceutical Industry:
Considering its organochlorine nature, 1-[2-(Ammoniooxy)ethoxy]benzene chloride could potentially be utilized in the development of pharmaceutical compounds, where its specific functional groups may contribute to desired biological activities.
Used in Agrochemical Industry:
Given its potential reactivity and chemical properties, 1-[2-(Ammoniooxy)ethoxy]benzene chloride may find applications in the agrochemical industry, possibly as a precursor for the synthesis of pesticides or other agrochemicals.

InChI:InChI=1/C8H11NO2.ClH/c9-11-7-6-10-8-4-2-1-3-5-8;/h1-5H,6-7,9H2;1H

Upstream product

• 589-10-6 phenoxyethyl bromide 
• 338406-38-5 N-(2-phenoxyethoxy)phthalimide 

Downstream Products

• 1597430-53-9 C₁₇H₂₁N₃O₇ 
• 714-20-5 2-Phenoxy-ethoxyguanidin 

Relevant academic research and scientific papers

4-alkyloxyimino derivatives of uridine-5′-triphosphate: Distal modification of potent agonists as a strategy for molecular probes of P2Y 2, P2Y4, and P2Y6 receptors

Extended N4-(3-arylpropyl)oxy derivatives of uridine-5′-triphosphate were synthesized and potently stimulated phospholipase C stimulation in astrocytoma cells expressing G protein-coupled human (h) P2Y receptors (P2YRs) activated by UTP (P2Y2/4R) or UDP (P2Y6R). The potent P2Y4R-selective N4-(3- phenylpropyl)oxy agonist was phenyl ring-substituted or replaced with terminal heterocyclic or naphthyl rings with retention of P2YR potency. This broad tolerance for steric bulk in a distal region was not observed for dinucleoside tetraphosphate agonists with both nucleobases substituted. The potent N 4-(3-(4-methoxyphenyl)-propyl)oxy analogue 19 (EC50: P2Y2R, 47 nM; P2Y4R, 23 nM) was functionalized for chain extension using click tethering of fluorophores as prosthetic groups. The BODIPY 630/650 conjugate 28 (MRS4162) exhibited EC50 values of 70, 66, and 23 nM at the hP2Y2/4/6Rs, respectively, and specifically labeled cells expressing the P2Y6R. Thus, an extended N4-(3- arylpropyl)oxy group accessed a structurally permissive region on three G q-coupled P2YRs, and potency and selectivity were modulated by distal structural changes. This freedom of substitution was utilized to design of a pan-agonist fluorescent probe of a subset of uracil nucleotide-activated hP2YRs.